Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Thyroglobulin levels (ng/ml)</td><td class="align_center">Mean</td><td class="align_center">SD</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Max TG (before therapy)</td><td class="align_center">5,977.72</td><td class="align_center">13,692.36</td></tr><tr><td class="align_left">1 m</td><td class="align_center">1,515.15</td><td class="align_center">3,550.66</td></tr><tr><td class="align_left">3 m</td><td class="align_center">980.51</td><td class="align_center">3,133.72</td></tr><tr><td class="align_left">12 m</td><td class="align_center">1,640.60</td><td class="align_center">3,566.92</td></tr><tr><td class="align_left">24 m</td><td class="align_center">2,643.75</td><td class="align_center">5,257.11</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Thyroglobulin levels (mean ± SD) at different time points.</div>

International Journal of Endocrinology

tab3

Table 3

Table 3: Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria 

Table 3 | Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria 